Abstract
Humans have used nonsteroidal anti-inflammatory dmgs (NSAIDs) for several thousand years, ever since the analgesic and 'antiphlogistic' (anti-inflammatory) properties of the salicylate-containing willow bark were recognized. Recently, their use has reached unprecedented levels, as the increasing longevity of populations increases the burden of painful degenerative joint disease, and as the recognition of the antiplatelet and anticancer properties of aspirin creates new uses for this old dmg. This chapter deals with the features, causation, and epidemiology of the adverse effects of NSAIDs on the gastrointestinal (GI) tract. It does not discuss their treatment, which is dealt with elsewhere in this book under each individual disorder.
| Original language | English |
|---|---|
| Title of host publication | Clinical Gastroenterology and Hepatology: The Modern Clinician’s Guide |
| Editors | Wilfred M. Weinstein, Hawkey C. J., Jaime Bosch |
| Place of Publication | U.K. |
| Publisher | Elsevier |
| Pages | 133-137 |
| Number of pages | 5 |
| Edition | 1st |
| ISBN (Print) | 0323027512 |
| Publication status | Published - 2005 |